Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression

Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression

Saved in:

Bibliographic Details
Main Authors:	Dhanraj Ganapathy, Saravanan Sekaran, Pasiyappazham Ramasamy
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024003480
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intracellular microbiome in oral cancer progression
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Universal Repository for patients with oral cancer and oral premalignant lesions (UROC)
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Scleraxis (SCX): A novel therapeutic target in the malignant transformation of oral potentially malignant disorders
by: Bharathi Selvaraj, et al.
Published: (2024-06-01)

Comprehensive Analysis of FBXO43 Expression and Its Prognostic and Therapeutic Implications in Osteosarcoma
by: Jiang Jin, et al.
Published: (2025-01-01)

miR-1266-5p as a prognostic marker and miR-1255-5p/DAB2IP axis a therapeutic target in malignant transformation of oral submucous fibrosis
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer
by: Saravanan Sekaran, et al.
Published: (2024-03-01)

Pyrotinib: A promising therapeutic prospect for treating metastatic salivary gland cancer
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Tumor-grafted chorioallantoic membrane model: A versatile approach to study head and neck squamous cell carcinoma physiopathology and therapeutics testing
by: Saravanan Sekaran, et al.
Published: (2024-06-01)

Two long-term, risk-free treatments for oral cancer: Sarcodictyin and Elutherobin
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy
by: Saravanan Sekaran, et al.
Published: (2024-06-01)

Comment on “Unlocking the therapeutic potential of microalgal astaxanthin a super antioxidant in oral cancer and associated ailments”
by: Antonyraj Matharasi Perianaika Anahas, et al.
Published: (2024-09-01)

Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies
by: Bharathi Selvaraj, et al.
Published: (2024-06-01)

Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer?
by: Saravanan Sekaran
Published: (2024-06-01)

Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent?
by: Deepavalli Arumuganainar, et al.
Published: (2024-09-01)

Utilizing chitosan nanoparticles in oral cancer treatment: A promising approach
by: Revathi Duraisamy, et al.
Published: (2024-06-01)

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
by: Na Liu, et al.
Published: (2017-01-01)

Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
by: Jing-Xuan Xu, et al.
Published: (2025-12-01)

Predictive and Prognostic Molecular Markers of Oral Cancers and Potential Therapeutic Agents Targeting These Markers
by: Shilpa Jain, et al.
Published: (2024-08-01)

Deciphering the interactome of Ataxin-2 and TDP-43 in iPSC-derived neurons for potential ALS targets.
by: Yuan Tian, et al.
Published: (2024-01-01)

FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy
by: Na Zhang, et al.
Published: (2025-02-01)

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
by: Mengru Liu, et al.
Published: (2025-01-01)

Exploring the Molecular Modalities in the Pathogenesis of Diabetic Kidney Disease with a Focus on the Potential Therapeutic Implications
by: Lyubomir Gaydarski, et al.
Published: (2024-12-01)

Probiotic bacteria therapy for oral cancer treatment: An emerging approach on bacteriocin and exopolysaccharides
by: Sivagnanavelmurugan Madasamy, et al.
Published: (2024-03-01)

Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer
by: Meena K. Sakharkar, et al.
Published: (2013-01-01)

Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4
by: Arushi Vats, et al.
Published: (2025-02-01)

Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets
by: Hao-Shuai Yang, et al.
Published: (2025-01-01)

Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
by: Maura Rojas-Pirela, et al.
Published: (2025-02-01)

Integrated bioinformatics analysis to explore potential therapeutic targets and drugs for small cell carcinoma of the esophagus
by: Maofei Zhu, et al.
Published: (2025-01-01)

PfFBXO1 is essential for inner membrane complex formation in Plasmodium falciparum during both asexual and transmission stages
by: Sreelakshmi K. Sreenivasamurthy, et al.
Published: (2025-02-01)

Pan-cancer analysis of SOX2: Prognostic implications and potential as a therapeutic target in immune checkpoint modulation
by: Shoukai Yu, et al.
Published: (2025-02-01)

Role of proteases in oral carcinogenesis: Insights into the cancer degradome and therapeutic implications
by: Gargi S. Sarode, et al.
Published: (2024-06-01)

Exploring the potential of bioluminescence in oral cancer
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01)

TDP-43 as a potential retinal biomarker for neurodegenerative diseases
by: Margit Glashutter, et al.
Published: (2025-02-01)

Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
by: Shahzad Ali Jiskani
Published: (2025-06-01)

Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
by: Simon A. Young, et al.
Published: (2012-01-01)

Exploring the therapeutic effects of seaweed bioactive compounds in oral cancer
by: Ramadurai Murugan, et al.
Published: (2024-06-01)

Single-cell technologies for dissecting heterogeneity in oral tumours: Implications for precision therapy
by: Sundaram Vickram, et al.
Published: (2024-06-01)

Selenium in cancer management: exploring the therapeutic potential
by: Lingwen He, et al.
Published: (2025-01-01)

Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets
by: Soyoung Jeon, et al.
Published: (2025-01-01)

Comment on “Exploring PD-1 methylation in oral cancer: A crucial frontier in immunotherapy”
by: Muthupandian Saravanan
Published: (2024-09-01)